Jiang S - Search Results

1

Development of therapeutics for treatment of Ebola virus infection.

Li H, Ying T, Yu F, Lu L, Jiang S. Li H, et al. Among authors: jiang s. Microbes Infect. 2015 Feb;17(2):109-17. doi: 10.1016/j.micinf.2014.11.012. Epub 2014 Dec 11. Microbes Infect. 2015. PMID: 25498866 Free article. Review.

2

Surface exposure of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane fusion process: interaction with gp41 fusion core.

Lu L, Zhu Y, Huang J, Chen X, Yang H, Jiang S, Chen YH. Lu L, et al. Among authors: jiang s. J Biol Chem. 2008 Jun 13;283(24):16723-31. doi: 10.1074/jbc.M801083200. Epub 2008 Apr 11. J Biol Chem. 2008. PMID: 18408000 Free PMC article.

3

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. Du L, et al. Among authors: jiang s. Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Epub 2009 Feb 9. Nat Rev Microbiol. 2009. PMID: 19198616 Free PMC article. Review.

4

Research and development of universal influenza vaccines.

Du L, Zhou Y, Jiang S. Du L, et al. Among authors: jiang s. Microbes Infect. 2010 Apr;12(4):280-6. doi: 10.1016/j.micinf.2010.01.001. Epub 2010 Jan 15. Microbes Infect. 2010. PMID: 20079871 Free article. Review.

5

Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides.

Chen X, Lu L, Qi Z, Lu H, Wang J, Yu X, Chen Y, Jiang S. Chen X, et al. Among authors: jiang s. J Biol Chem. 2010 Aug 13;285(33):25506-15. doi: 10.1074/jbc.M110.101170. Epub 2010 Jun 10. J Biol Chem. 2010. PMID: 20538590 Free PMC article.

6

Identification of a gp41 core-binding molecule with homologous sequence of human TNNI3K-like protein as a novel human immunodeficiency virus type 1 entry inhibitor.

Zhu Y, Lu L, Xu L, Yang H, Jiang S, Chen YH. Zhu Y, et al. Among authors: jiang s. J Virol. 2010 Sep;84(18):9359-68. doi: 10.1128/JVI.00644-10. Epub 2010 Jun 30. J Virol. 2010. PMID: 20592080 Free PMC article.

7

In vitro selection and characterization of HIV-1 variants with increased resistance to sifuvirtide, a novel HIV-1 fusion inhibitor.

Liu Z, Shan M, Li L, Lu L, Meng S, Chen C, He Y, Jiang S, Zhang L. Liu Z, et al. Among authors: jiang s. J Biol Chem. 2011 Feb 4;286(5):3277-87. doi: 10.1074/jbc.M110.199323. Epub 2010 Nov 23. J Biol Chem. 2011. PMID: 21098485 Free PMC article.

8

Design, synthesis, and biological activity of novel 5-((arylfuran/1H-pyrrol-2-yl)methylene)-2-thioxo-3-(3-(trifluoromethyl)phenyl)thiazolidin-4-ones as HIV-1 fusion inhibitors targeting gp41.

Jiang S, Tala SR, Lu H, Abo-Dya NE, Avan I, Gyanda K, Lu L, Katritzky AR, Debnath AK. Jiang S, et al. J Med Chem. 2011 Jan 27;54(2):572-9. doi: 10.1021/jm101014v. Epub 2010 Dec 29. J Med Chem. 2011. PMID: 21190369

9

Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines.

Jiang S, Li R, Du L, Liu S. Jiang S, et al. Protein Cell. 2010 Apr;1(4):342-354. doi: 10.1007/s13238-010-0054-6. Epub 2010 May 8. Protein Cell. 2010. PMID: 21203946 Free PMC article. Review.

10

Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.

Li L, Tan S, Lu H, Lu L, Yang J, Jin H, Liu S, Jiang S. Li L, et al. Among authors: jiang s. J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):384-92. doi: 10.1097/QAI.0b013e31820a4a8d. J Acquir Immune Defic Syndr. 2011. PMID: 21239999 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,790 results

Search Page

Filters